All News about Cybin Inc
![](https://mms.businesswire.com/media/20231004309675/en/1906466/22/Cybin_Side_Logo_%28004%29.jpg)
Cybin to Present at the Jefferies Inaugural Biotech CNS/Neuro Summit
October 04, 2023
From Cybin Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/10/03/psychedelic_chemistry__olia_danilevich_by_pexels.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/02/psychedelic_chemistry_olia_danilevich_by_pexels_-_copy.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20231003190038/en/1904925/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/29/psyched.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230927069776/en/1900342/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/psilocybin_psychologist_krakenimages.com_and_cannabis_pic_by_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/advanced_technology_clinic_dmt_psilocybin_mdma_bacsica_aiyoshi597_gisele_yashar_and_gorodenkoff_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/22/psyched.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230926212750/en/1899040/22/Cybin_Side_Logo.jpg)
![](https://mms.businesswire.com/media/20230925617402/en/1897750/22/Cybin_Side_Logo_%28004%29.jpg)
Cybin to Participate in the Cantor Global Healthcare Conference
September 25, 2023
From Cybin Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/09/21/advanced_technology_clinic_dmt_psilocybin_mdma_bacsica_aiyoshi597_gisele_yashar_and_metamorworks_on_shutterstock.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230921821461/en/1896866/22/Cybin_Side_Logo.jpg)
Cybin Announces Date of Annual and Special Meeting of Shareholders
September 21, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230921411645/en/1896011/22/Cybin_Side_Logo.jpg)
Cybin Completes Enrollment in Phase 2 Study of CYB003 in Major Depressive Disorder
September 21, 2023
From Cybin Inc.
Via Business Wire
![](https://www.financialnewsmedia.com/wp-content/uploads/2021/06/FNM-GA-Logo1-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/20/image13.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/19/image11.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/18/finance_and_psychedelics_anaterate_sergeitokmakov__by_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-finding-magnify.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/12/finance_and_psychedelics_chrissmith12_bru-no_by_pixabay_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/08/psyched.png?width=1200&height=800&fit=crop)
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
September 11, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://cdn.benzinga.com/files/images/story/2023/09/05/meo-dmt_clinical_studies_poptika_on_shutterstock_and_harbin_on_wikimedia_commons.jpg?width=1200&height=800&fit=crop)
Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT
September 05, 2023
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/images/story/2023/09/01/psyched.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.